Title: Double Trouble: Post COVID Pulmonary Sequelae

Authors: Dr Karunya Sarangam, Dr Vegi. Surya Narayana, Dr Darsi Hemalatha, Dr Sankara Rao Meegada, Dr G.Rajasekharam, Dr M. Mohana Pradeepika, Dr A.Bhagyaraj, Dr Sreenivasa Rao Kachepalli

 DOI: https://dx.doi.org/10.18535/jmscr/v10i2.13

Abstract

Background: Coronavirus disease 2019 (COVID-19) is an infectious acute respiratory disease caused by a novel coronavirus. The World Health Organization (WHO) was informed of cases of pneumonia of unknown microbial aetiology associated with Wuhan City, Hubei Province, China on 31 December 20191,2. The first case was reported in India on 27th January 2020 and in Srikakulam on 25th April 2020. As per WHO, patients will recover with an incubation period of 10 to 14 days, sometimes COVID symptoms can remain for more than 20 days up to 45days due to the long-term effect of COVID and patients develop Post COVID complications. Multi-organ involvement seen in patients who had a severe illness, lung being most commonly involved. Other organs involved are the heart, brain, vascular system, kidney, skin4. Here, we provide a comprehensive review on complications of the respiratory system arising in post-COVID patients depicted as post-COVID pulmonary sequelae

Aim of the Study: To evaluate the post COVID pulmonary complications, treat the cause and prevent disease progression

Materials & Methods: This is a prospective observational study conducted on 77 patients recovered from COVID-19 for a duration of 6months, in Great eastern medical school & hospital, Srikakulam, Andhra Pradesh which was a District COVID hospital. The study was done in COVID patients after recovery, within a duration of 1month to 6months with a confirmed diagnosis of COVID-19 in the second wave in the year 2021. A register would be made for data collection for both out-patients and in-patients. Information will be collected regarding symptoms, history, personal history. HRCT chest, sputum bacterial culture, TRUENAAT is done to assess complications and prevent them. The study was conducted after obtaining consent from patients.

Results: Among 77 study populations, the analysis showed males were 71.43% and females were 28.57% with an age group of 41-60years is most commonly involved. Most of the patients presented with a duration of symptoms >1month i.e.,29.87%. Most common complication encountered was pulmonary fibrosis 23.37%, Fungal pneumonia 10.3%, Allergic rhinitis 10.3%, death 10.38%, pleural diseases 9%, diabetes 9%, pulmonary TB 6.49%, Extrapulmonary(pleural) TB- 5.19%, Extrapulmonary complications 2.59%.

Conclusion: The pulmonary sequelae of COVID-19 after the acute phase of COVID-19 is increasingly being appreciated. COVID-19 affects people of all age groups and gender. It neither spares people with comorbidities nor those without any comorbidities. Social distancing, proper mask and hand hygiene will be the long-lasting self-disciplinary measures to curtail the spread of the disease.

Keywords: Post COVID complications, COVID-19, Pulmonary sequelae

References

  1. Sohrabi C, Alsafi Z, O'neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International journal of surgery. 2020 Apr 1;76:71-6.
  2. Singhal T. A review of coronavirus disease-2019 (COVID-19). The indian journal of pediatrics. 2020 Apr;87(4):281-6.
  3. https://bestpractice.bmj.com/topics/en-gb/3000201.
  4. Gavriatopoulou M, Korompoki E, Fotiou D, Ntanasis-Stathopoulos I, Psaltopoulou T, Kastritis E, Terpos E, Dimopoulos MA. Organ-specific manifestations of COVID-19 infection. Clinical and experimental medicine. 2020 Jul 27:1-4.
  5. Sharma A, Tiwari S, Deb MK, Marty JL. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. International journal of antimicrobial agents. 2020 Aug 1;56(2):106054.
  6. Yan Z, Yang M, Lai CL. Long COVID-19 syndrome: a comprehensive review of its effect on various organ systems and recommendation on rehabilitation plans. Biomedicines. 2021 Aug;9(8):966.
  7. https://www.idsociety.org/COVID-19-real-time-learning-network/disease-manifestations--complications/post-COVID-syndrome/#ECH
  8. https://www.blf.org.uk/support-for-you/long-COVID/what-is-long-COVID
  9. Moghimi N, Di Napoli M, Biller J, Siegler JE, Shekhar R, McCullough LD, Harkins MS, Hong E, Alaouieh DA, Mansueto G, Divani AA. The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection. Current neurology and neuroscience reports. 2021 Sep;21(9):1-7.
  10. Dayal AK, Sinha V. Trend of allergic rhinitis post COVID-19 pandemic: a retrospective observational study. Indian Journal of Otolaryngology and Head & Neck Surgery. 2020 Oct 20:1-3.
  11. Hussein M, Haq IU, Hameed M, Thomas M, Elarabi A, Allingawi M, Al-Bozom I. Pleural effusion as an isolated finding in COVID-19 infection. Respiratory Medicine Case Reports. 2020 Jan 1;31:101269.

Corresponding Author

Dr Karunya Sarangam

Junior Resident,Dept of Respiratory Medicine, GEMS Hospital, Srikakulam